FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046124259> ?p ?o ?g. }

• W2046124259 endingPage "768" @default.
• W2046124259 startingPage "755" @default.
• W2046124259 abstract "Because of the heterogeneous nature of glioma, biopsies performed should be targeted at the most anaplastic region. Several functional magnetic resonance imaging (MRI) or positron emission tomography (PET) techniques have been proposed for identifying the most anaplastic tumor area. However, it is unclear whether the recommended biopsy targets based on these various functional imaging modalities correspond with each other. Thus, the purpose was to evaluate whether they identify similar target areas.A total of 61 patients with suspected glioma were assessed within 2.3 +/- 3.5 days by MRI, 18F-fluorothymidine-, and 18F-fluorodeoxyglucose-PET. Thirty-five patients underwent gross total resection and 26 were stereotactically biopsied. MRI was performed on a 1.5 Tesla broadband transmit/receive system, using a double-resonant birdcage coil. The MRI protocol comprised of sodium (23Na)-MRI (3D-radial projection imaging), proton spectroscopic imaging (1H-MRSI, point-resolved spectroscopy), arterial spin-labeling (ASL) perfusion MRI, dynamic contrast-enhanced (DCE) MRI, and dynamic-susceptibility-weighted (DSC) perfusion MRI after a single dose each of gadobenate dimeglumine. Also, apparent diffusion coefficient (ADC) maps were processed from diffusion tensor images. Image analysis comprised a detailed semiquantitative region of interest analysis of the different parameter values as well as visual identification of the most conspicuous tumor areas on parameter maps, for example, areas with maximum tumor perfusion, highest metabolite ratios of choline-containing compounds/N-acetyl-aspartate, or lowest ADC values within tumor tissue. Colocalization of these areas was then assessed.Regarding tumor vascularity-related parameters and tumor proliferation-related parameters, the higher the glioma grade the higher were the respective parameters in semiquantitative analysis. ADC values decreased with glioma grade. In the whole study population comprising low- (N = 15) and high-grade gliomas (N = 42), except for 23Na-MRI, there was good (>50%) or perfect (100%) agreement of the tumor areas with highest values on parameter images in the majority of cases (>80%), that is, tumor areas with increased thymidine-uptake and highest choline, both suggestive of increased tumor proliferation, and elevated microcirculation as demonstrated by DSC-, arterial spin-labeling-, and DCE-MRI. 23Na-MRI depicted the highest signal within necrotic tumor areas, but non-necrotic gliomas also showed a perfect agreement in more than 61%. 18F-fluorothymidine-PET, DSC-, and DCE-MRI, diffusion-weighted imaging as well as MR spectroscopic imaging correctly detected no glioma heterogeneity in all 15 histologically proven grade II gliomas but identified suspicious areas in all 3 nonenhancing grade III gliomas.Both imaging techniques that depict microcirculation and techniques that visualize proliferation identify similar target areas." @default.
• W2046124259 created "2016-06-24" @default.
• W2046124259 creator A5005956796 @default.
• W2046124259 creator A5006815201 @default.
• W2046124259 creator A5010632119 @default.
• W2046124259 creator A5013671245 @default.
• W2046124259 creator A5026818160 @default.
• W2046124259 creator A5027198784 @default.
• W2046124259 creator A5035226599 @default.
• W2046124259 creator A5035960100 @default.
• W2046124259 creator A5036534553 @default.
• W2046124259 creator A5049461288 @default.
• W2046124259 creator A5057675610 @default.
• W2046124259 creator A5061037633 @default.
• W2046124259 creator A5072193667 @default.
• W2046124259 creator A5077999569 @default.
• W2046124259 creator A5081133327 @default.
• W2046124259 date "2010-12-01" @default.
• W2046124259 modified "2023-09-25" @default.
• W2046124259 title "Biopsy Targeting Gliomas" @default.
• W2046124259 cites W1256849100 @default.
• W2046124259 cites W1489313047 @default.
• W2046124259 cites W1971324201 @default.
• W2046124259 cites W1971571088 @default.
• W2046124259 cites W1973760073 @default.
• W2046124259 cites W1979741194 @default.
• W2046124259 cites W1990781055 @default.
• W2046124259 cites W1992206281 @default.
• W2046124259 cites W1994192509 @default.
• W2046124259 cites W2012258756 @default.
• W2046124259 cites W2013307859 @default.
• W2046124259 cites W2021496866 @default.
• W2046124259 cites W2022912277 @default.
• W2046124259 cites W2024143954 @default.
• W2046124259 cites W2026901966 @default.
• W2046124259 cites W2030331570 @default.
• W2046124259 cites W2032443466 @default.
• W2046124259 cites W2035348090 @default.
• W2046124259 cites W2042811218 @default.
• W2046124259 cites W2050241533 @default.
• W2046124259 cites W2065775807 @default.
• W2046124259 cites W2073594796 @default.
• W2046124259 cites W2077236011 @default.
• W2046124259 cites W2079034377 @default.
• W2046124259 cites W2081705770 @default.
• W2046124259 cites W2082793256 @default.
• W2046124259 cites W2082984639 @default.
• W2046124259 cites W2086111208 @default.
• W2046124259 cites W2091011326 @default.
• W2046124259 cites W2099233066 @default.
• W2046124259 cites W2101120359 @default.
• W2046124259 cites W2107547469 @default.
• W2046124259 cites W2110952998 @default.
• W2046124259 cites W2112648127 @default.
• W2046124259 cites W2115714180 @default.
• W2046124259 cites W2125587122 @default.
• W2046124259 cites W2125687380 @default.
• W2046124259 cites W2130019868 @default.
• W2046124259 cites W2131385778 @default.
• W2046124259 cites W2147406086 @default.
• W2046124259 cites W2147816079 @default.
• W2046124259 cites W2153428956 @default.
• W2046124259 cites W2161240017 @default.
• W2046124259 cites W2162184131 @default.
• W2046124259 cites W2165231045 @default.
• W2046124259 cites W2168932357 @default.
• W2046124259 cites W2169293905 @default.
• W2046124259 cites W2169871331 @default.
• W2046124259 cites W2764360364 @default.
• W2046124259 cites W305773089 @default.
• W2046124259 doi "https://doi.org/10.1097/rli.0b013e3181ec9db0" @default.
• W2046124259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20829706" @default.
• W2046124259 hasPublicationYear "2010" @default.
• W2046124259 type Work @default.
• W2046124259 sameAs 2046124259 @default.
• W2046124259 citedByCount "58" @default.
• W2046124259 countsByYear W20461242592012 @default.
• W2046124259 countsByYear W20461242592013 @default.
• W2046124259 countsByYear W20461242592014 @default.
• W2046124259 countsByYear W20461242592015 @default.
• W2046124259 countsByYear W20461242592016 @default.
• W2046124259 countsByYear W20461242592017 @default.
• W2046124259 countsByYear W20461242592018 @default.
• W2046124259 countsByYear W20461242592019 @default.
• W2046124259 countsByYear W20461242592020 @default.
• W2046124259 countsByYear W20461242592021 @default.
• W2046124259 countsByYear W20461242592022 @default.
• W2046124259 crossrefType "journal-article" @default.
• W2046124259 hasAuthorship W2046124259A5005956796 @default.
• W2046124259 hasAuthorship W2046124259A5006815201 @default.
• W2046124259 hasAuthorship W2046124259A5010632119 @default.
• W2046124259 hasAuthorship W2046124259A5013671245 @default.
• W2046124259 hasAuthorship W2046124259A5026818160 @default.
• W2046124259 hasAuthorship W2046124259A5027198784 @default.
• W2046124259 hasAuthorship W2046124259A5035226599 @default.
• W2046124259 hasAuthorship W2046124259A5035960100 @default.
• W2046124259 hasAuthorship W2046124259A5036534553 @default.
• W2046124259 hasAuthorship W2046124259A5049461288 @default.

• next